Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

Conditions:   COVID-19;   Deep Vein Thrombosis;   Anticoagulants and Bleeding Disorders;   Critical Illness Interventions:   Drug: Enoxaparin;   Drug: Heparin Sponsor:   University Hospital, Ghent Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials